SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 59 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,000 | -28.6% | 15,695 | +12.5% | 0.00% | – |
| Q4 2017 | $7,000 | -46.2% | 13,953 | -2.7% | 0.00% | – |
| Q3 2017 | $13,000 | +62.5% | 14,345 | +0.7% | 0.00% | – |
| Q2 2017 | $8,000 | -20.0% | 14,248 | -15.1% | 0.00% | – |
| Q1 2017 | $10,000 | -23.1% | 16,774 | -0.2% | 0.00% | – |
| Q4 2016 | $13,000 | -53.6% | 16,803 | +0.4% | 0.00% | – |
| Q3 2016 | $28,000 | -6.7% | 16,729 | +0.4% | 0.00% | – |
| Q2 2016 | $30,000 | -11.8% | 16,658 | +16.7% | 0.00% | – |
| Q1 2016 | $34,000 | +17.2% | 14,269 | +12.5% | 0.00% | – |
| Q4 2015 | $29,000 | 0.0% | 12,685 | 0.0% | 0.00% | – |
| Q3 2015 | $29,000 | +16.0% | 12,685 | -14.3% | 0.00% | – |
| Q2 2014 | $25,000 | -40.5% | 14,796 | -9.1% | 0.00% | – |
| Q1 2014 | $42,000 | +162.5% | 16,274 | +59.9% | 0.00% | – |
| Q4 2013 | $16,000 | – | 10,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,034,949 | $1,553,000 | 2.72% |
| Third Security, LLC | 13,238,268 | $10,095,000 | 0.54% |
| MSD Partners, L.P. | 4,118,402 | $3,141,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 3,031,953 | $2,312,000 | 0.13% |
| Alyeska Investment Group, L.P. | 10,000,000 | $7,626,000 | 0.06% |
| BARD ASSOCIATES INC | 87,999 | $67,000 | 0.03% |
| Alyeska Investment Group, L.P. | 4,586,592 | $3,498,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $96,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $763,000,000 | 0.02% |
| HAMILTON LANE ADVISORS LLC | 23,855 | $18,000 | 0.01% |